# An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

> **NCT02682264** · PHASE3 · COMPLETED · sponsor: **Cassiopea SpA** · enrollment: 609 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** CB-03-01 cream, 1%

## Key facts

- **NCT ID:** NCT02682264
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-09
- **Primary completion:** 2018-08-31
- **Final completion:** 2018-08-31
- **Target enrollment:** 609 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682264, "An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02682264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*